XML 44 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock Based Compensation - Schedule of Stock Options and SARs Transactions (Details) - Stock Options And SARs - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Number of Stock Options/SARs    
Beginning balance (in shares) 9,969 10,186
Granted (in shares) 2 1,976
Exercised (in shares) (4,282) (448)
Forfeited (in shares) (192) (984)
Ending balance (in shares) 5,497 10,730
Vested or Expected to Vest (in shares) 5,344 10,407
Exercisable (in shares) 3,686 6,906
Weighted Average Exercise Price    
Beginning balance (in USD per share) $ 84.37 $ 84.08
Granted (in USD per share) 97.64 81.66
Exercised (in USD per share) 91.63 64.18
Forfeited (in USD per share) 84.26 98.64
Ending balance (in USD per share) 78.73 83.13
Vested or Expected to Vest (in USD per share) 79.05 83.65
Exercisable (in USD per share) $ 84.18 $ 92.39
Additional Disclosures    
Intrinsic value of stock options/SARs exercised $ 122 $ 8
Intrinsic value of stock options/SARs outstanding $ 194 $ 95
Weighted average remaining contractual life for stock options/SARs outstanding (in years) 4 years 3 months 18 days 4 years 3 months 18 days
Intrinsic value of stock options/SARs vested or expected to vest $ 187 $ 90
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) 4 years 3 months 18 days 4 years 3 months 18 days
Aggregate intrinsic value for exercisable units $ 114 $ 38
Weighted average remaining contractual life for exercisable options/SARs (in years) 3 years 8 months 12 days 3 years 2 months 12 days